Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression

por Wang, Chuying, Bai, Feng, Zhang, Li-han, Scott, Alexandria, Li, Enxiao, Pei, Xin-Hai
Publicado en Breast Cancer Res (2018)

Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer...

por Fan, Yangwei, Ma, Ke, Jing, Jiayu, Wang, Chuying, Hu, Yuan, Shi, Yu, Li, Enxiao, Geng, Qianqian
Publicado en J Cancer (2020)

HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

por YANG, HAIXIA, ZHOU, JIUPENG, MI, JIANQIANG, MA, KE, FAN, YANGWEI, NING, JING, WANG, CHUYING, WEI, XIN, ZHAO, HUADONG, LI, ENXIAO
Publicado en Oncol Rep (2015)

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

por Fan, Yangwei, Ma, Ke, Wang, Chuying, Ning, Jing, Hu, Yuan, Dong, Danfeng, Dong, Xuyuan, Geng, Qianqian, Li, Enxiao, Wu, Yinying
Publicado en Onco Targets Ther (2016)

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades

por Shi, Yu, Fan, Yangwei, Hu, Yuan, Jing, Jiayu, Wang, Chuying, Wu, Yinying, Geng, Qianqian, Dong, Xuyuan, Li, Enxiao, Dong, Danfeng
Publicado en J Cell Mol Med (2019)

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer

por Ma, Ke, Fan, Yangwei, Dong, Xuyuan, Dong, Danfeng, Guo, Yuyan, Wei, Xin, Ning, Jing, Geng, Qianqian, Wang, Chuying, Hu, Yuan, Li, Mengya, Niu, Wenxia, Li, Enxiao, Wu, Yinying
Publicado en Oncotarget (2017)

PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors

por Bai, Feng, Liu, Shiqin, Liu, Xiong, Hollern, Daniel P., Scott, Alexandria, Wang, Chuying, Zhang, Lihan, Fan, Cheng, Fu, Li, Perou, Charles M., Zhu, Wei-Guo, Pei, Xin-Hai
Publicado en Breast Cancer Res (2021)